EichorEICHOR
Location: Hot Springs Synced from ClinicalTrials.gov · August 07, 2026

Clinical studies recruiting near Hot Springs

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · CHI Saint Vincent Cancer Center Hot Springs · NRG Oncology · NCT05174169Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SL
Phase 3 · CHI Saint Vincent Cancer Center Hot Springs · National Cancer Institute (NCI) · NCT04269902BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer
Phase 3 · Genesis Cancer and Blood Institute Hot Springs (Harmony Park · BeOne Medicines · NCT07492641Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children
Phase 2 · HealthStar Research of Hot Springs PLLC /ID# 234609 · AbbVie · NCT03339128Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
Phase N/A · CHI Saint Vincent Cancer Center Hot Springs · Alliance for Clinical Trials in Oncology · NCT04242095Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials
NA · CHI Saint Vincent Cancer Center Hot Springs · Eastern Cooperative Oncology Group · NCT05108298Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Phase 3 · CHI Saint Vincent Cancer Center Hot Springs · ECOG-ACRIN Cancer Research Group · NCT04566328Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
NA · CHI Saint Vincent Cancer Center Hot Springs · NRG Oncology · NCT05080673Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
Phase 2 · CHI Saint Vincent Cancer Center Hot Springs · SWOG Cancer Research Network · NCT04205968Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head
Phase 2 · CHI Saint Vincent Cancer Center Hot Springs · ECOG-ACRIN Cancer Research Group · NCT02734537S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac
Phase 3 · CHI Saint Vincent Cancer Center Hot Springs · SWOG Cancer Research Network · NCT03418961S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic
NA · CHI Saint Vincent Cancer Center Hot Springs · SWOG Cancer Research Network · NCT03723928Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabo
Phase 2 · CHI Saint Vincent Cancer Center Hot Springs · National Cancer Institute (NCI) · NCT03866382Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung
Phase 3 · CHI Saint Vincent Cancer Center Hot Springs · National Cancer Institute (NCI) · NCT04267848Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Phase 3 · CHI Saint Vincent Cancer Center Hot Springs · ECOG-ACRIN Cancer Research Group · NCT03937635Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Phase 3 · CHI Saint Vincent Cancer Center Hot Springs · National Cancer Institute (NCI) · NCT04181060Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ C
Phase 3 · CHI Saint Vincent Cancer Center Hot Springs · Children's Oncology Group · NCT03067181Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Ch
Phase 3 · HealthStar Research of Hot Springs /ID# 273256 · AbbVie · NCT05125302A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer
Phase 3 · Genesis Cancer and Blood Institute · Eli Lilly and Company · NCT07174336Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Phase N/A · CHI Saint Vincent Cancer Center Hot Springs · SWOG Cancer Research Network · NCT04871542APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patient
Phase 2 · CHI Saint Vincent Cancer Center Hot Springs · National Cancer Institute (NCI) · NCT04858334Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
Phase 2 · CHI Saint Vincent Cancer Center Hot Springs · Alliance for Clinical Trials in Oncology · NCT02523014
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.